ACOUPLASMA SIGNED

Project "ACOUPLASMA" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

+-

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

AcouSort has developed a technological platform based on acoustic forces to separate, enrich and wash cells and other particles. This technique can perform almost any operation that is normally done by centrifugation in the biology or clinical lab. With an automated flow we can handle small samples and low cell concentrations. We are currently selling two R&D benchtop devices based on this technology, named AcouTrap and AcouWash. In our pipeline is AcouPlasma the first example of the company’s long-term strategy to provide components and modules for life science analytical/diagnostic devices. The AcouPlasma solution offers high quality separation of blood plasma from cells in whole blood in a chip, eliminating the need of time consuming and laborious centrifugation. Through a unique design it facilitates cost-effective automation and in line integration with the sample workflow required to take plasma-based laboratory tests to point-of-care. Hence, it has the potential to increase the patient safety, healthcare decision making efficacy and hospitals/laboratories efficiency, finances and reputation. The AcouPlasma module will be integrated into cartridges for Lab-on-Chip test devices to be sold by major life science companies in the in vitro diagnostic market. We have conducted technical feasibility studies with main players in the industry proving the functionality of the separation module for plasma analysis. With the current project we aim to accelerate the maturation of our disruptive solution for introduction into the global blood processing devices and consumables market. With the successful implementation of the Innovation Project we will be in a strong position to exploit a very significant market.